177 related articles for article (PubMed ID: 11811787)
21. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
[TBL] [Abstract][Full Text] [Related]
22. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.
Mariani SM; Krammer PH
Eur J Immunol; 1998 May; 28(5):1492-8. PubMed ID: 9603453
[TBL] [Abstract][Full Text] [Related]
23. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
24. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
25. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
Liu B; Fan Z
Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
[TBL] [Abstract][Full Text] [Related]
26. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
28. Fas ligand-mediated depletion of CD4 and CD8 lymphocytes by monomeric HIV-1-gp120.
Uchiyama J; Kishi S; Yagita H; Matsuzaki S; Koga Y
Arch Virol; 1997; 142(9):1771-85. PubMed ID: 9672636
[TBL] [Abstract][Full Text] [Related]
29. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.
Frank MH; Denton MD; Alexander SI; Khoury SJ; Sayegh MH; Briscoe DM
J Immunol; 2001 Feb; 166(4):2451-9. PubMed ID: 11160305
[TBL] [Abstract][Full Text] [Related]
30. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.
Drach J; Gsur A; Hamilton G; Zhao S; Angerler J; Fiegl M; Zojer N; Raderer M; Haberl I; Andreeff M; Huber H
Blood; 1996 Sep; 88(5):1747-54. PubMed ID: 8781431
[TBL] [Abstract][Full Text] [Related]
31. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.
Smyth MJ; Krasovskis E; Sutton VR; Johnstone RW
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7024-9. PubMed ID: 9618532
[TBL] [Abstract][Full Text] [Related]
32. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.
Yerramasetti R; Gollapudi S; Gupta S
J Clin Immunol; 2002 Jan; 22(1):37-47. PubMed ID: 11958592
[TBL] [Abstract][Full Text] [Related]
33. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells.
Mantovani I; Cappellini A; Tazzari PL; Papa V; Cocco L; Martelli AM
J Cell Physiol; 2006 Jun; 207(3):836-44. PubMed ID: 16526059
[TBL] [Abstract][Full Text] [Related]
34. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction.
Hur YG; Yun Y; Won J
J Immunol; 2004 Jan; 172(1):79-87. PubMed ID: 14688312
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
36. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
Ceuppens JL; Van Vaeck F
Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
[TBL] [Abstract][Full Text] [Related]
37. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
39. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance.
Ruefli AA; Smyth MJ; Johnstone RW
Blood; 2000 Apr; 95(7):2378-85. PubMed ID: 10733510
[TBL] [Abstract][Full Text] [Related]
40. Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.
Walker LS; McLeod JD; Boulougouris G; Patel YI; Ellwood CN; Hall ND; Sansom DM
Immunology; 1999 Dec; 98(4):569-75. PubMed ID: 10594690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
